摘要 |
Provided herein are methods, compounds, and compositions for reducing expression of an AGPAT5 mRNA and protein in an animal. Also provided herein are methods, compounds, and compositions for reducing lipids, insulin resistance and/or glucose in an animal. Such methods, compounds, and compositions are useful to treat, prevent, delay, or ameliorate a cardiometabolic disease, disorder or condition, or a physiological marker thereof, in an individual in need. |
申请人 |
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA;IONIS PHARMACEUTICALS, INC. |
发明人 |
LUSIS, ALDONS, J.;PARKS, BRIAN;LEE, RICHARD |